Top compounds associated with response to TTC13


Feature Type Standardized
Nominal ANOVA
mRNA YM201636 GDSC1000 pan-cancer AAC 0.096 0.002
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.002
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.1 0.003
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.098 0.003
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.096 0.003
mRNA PL-DI CTRPv2 pan-cancer AAC 0.093 0.003
mRNA lenalidomide FIMM pan-cancer AAC -0.54 0.003
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.1 0.003
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
Download CSV